Press Releases

July 16, 2020
Zikani Therapeutics Appoints Chief Scientific and Medical Officer
Read Full Press Release

April 20, 2020
Zikani Therapeutics Completes Series A-1 Funding
Read Full Press Release

July 16, 2020
Zikani Therapeutics Appoints Chief Scientific and Medical Officer
Read Full Press Release

April 20, 2020
Zikani Therapeutics Completes Series A-1 Funding
Read Full Press Release

April 23, 2019
Macrolide Pharmaceuticals is now Zikani Therapeutics
Read Full Press Release

March 14, 2019
Macrolide Pharmaceuticals Appoints Sumit Aggarwal President and CEO
Read Full Press Release

September 4, 2018
Macrolide Pharmaceuticals Expands Leadership and Strengthens Expertise in Drug Development, Clinical Strategy, Finance and Business Development
Read Full Press Release

April 2, 2018
Macrolide Pharmaceuticals Appoints New President and CEO, Raises $20 Million in Investor Financing
Read Full Press Release

March 26, 2018
Macrolide Pharmaceuticals Announces Up to $6.8 Million from CARB-X to Develop Macrolide Antibiotics with Gram-Negative Activity
Read Full Press Release

March 15, 2018
Macrolide Pharmaceuticals Presents New Data on Tool to Differentiate Macrolide Antibacterial Drug by Risk of Liver Toxicity
Read Full Press Release

Presentations

Features and Perspectives